NCT02202135 - Evaluation of Ceftaroline Fosamil vs Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Complicated Skin and Soft Tissue Infection

Interventions

DRUG

Ceftaroline fosamil

IV ceftaroline 600mg every 8 hours

DRUG

Vancomycin

IV vancomycin 15mg/kg every 12 hours

DRUG

Aztreonam

IV aztreonam 1 g every 8 hours

Trial Locations (22)

Research site, Córdoba

Research site, Salvador

Research site, Passo Fundo

Research site, São José do Rio Preto

Research site, Pleven

Research site, Temuco

Research site, Zagreb

Research site, Athens

Research site, Haifa

Research site, Ramat Gan

Research site, Safed

Research site, Tel Aviv

Research site, Milan

Research site, Lodz

Research site, Bucharest

Research site, Dundee

Research site, Worcester

Research site, Granada

Research site, Terrassa

Research site, Ankara

Research site, Diyarbakır

Research site, Izmir